Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support
In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel
Spring Meetings Will Concentrate Everyone In New Orleans – Except The Nurses
Henry Neil, Natcher’s right arm, Back In The Job
Hammer to Produce US-USSR “Cancer Summit” March 29
SOCMA Asks Congress for Carcinogen Classification Probe
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









